Similar articles

• A possible case of myelopathy/tropical spastic paraparesis in an Argentinian woman with human T lymphocyte virus type II.

  Biglione MM, Pizarro M, Salomón HE, Berría MI. Biglione MM, et al. Clin Infect Dis. 2003 Aug 1;37(3):456-8. doi: 10.1086/376620. Epub 2003 Jul 17. Clin Infect Dis. 2003. PMID: 12884173
• Absence of HTLV-II co-infection in HTLV-I-associated myelopathy patients.

  Miyamoto K, Nakamura T, Nagataki S, Tomita N, Kitajima K. Miyamoto K, et al. Jpn J Cancer Res. 1992 May;83(5):415-7. doi: 10.1111/j.1349-7006.1992.tb01943.x. Jpn J Cancer Res. 1992. PMID: 1618692 Free PMC article.
• Relation between human T-lymphotropic virus type I and neurologic diseases in Panama: 1985-1990.

  Gracia F, Castillo LC, Larreategui M, Roberts B, Cedeño V, Heneine W, Blattner W, Kaplan JE, Levine PH. Gracia F, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 1;10(2):192-7. doi: 10.1097/00042560-199510020-00013. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7552485
• Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.

  Gessain A, Mahieux R. Gessain A, et al. Rev Neurol (Paris). 2012 Mar;168(3):257-69. doi: 10.1016/j.neurol.2011.12.006. Epub 2012 Mar 7. Rev Neurol (Paris). 2012. PMID: 22405461 Review.
• The epidemiology and disease outcomes of human T-lymphotropic virus type II.

  Roucoux DF, Murphy EL. Roucoux DF, et al. AIDS Rev. 2004 Jul-Sep;6(3):144-54. AIDS Rev. 2004. PMID: 15595431 Review.